Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer. (2020)
Attributed to:
Mendelian randomization to hypothesis-free causal inference
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ije/dyaa059
PubMed Identifier: 32356895
Publication URI: http://europepmc.org/abstract/MED/32356895
Type: Journal Article/Review
Volume: 49
Parent Publication: International journal of epidemiology
Issue: 4
ISSN: 0300-5771